It would be interesting to further study whether HER2 expression or HER2 T701 phosphorylation is a critical biomarker for the prediction of the antitumor efficiency of MEK inhibitors in melanoma cells or other cancer types. This evidence concerns the gene MAP2K7 and melanoma.